- 专利标题： TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
-
申请号： US16864226申请日： 2020-05-01
-
公开(公告)号： US20200377889A1公开(公告)日： 2020-12-03
- 发明人: Tracy Zimmermann , Amy Chan , Vasant R. Jadhav , Martin A. Maier , Kallanthottathil G. Rajeev
- 申请人： Alnylam Pharmaceuticals, Inc.
- 申请人地址： US MA Cambridge US MA Cambridge
- 专利权人： Alnylam Pharmaceuticals, Inc.,Alnylam Pharmaceuticals, Inc.
- 当前专利权人： Alnylam Pharmaceuticals, Inc.,Alnylam Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Cambridge US MA Cambridge
- 主分类号： C12N15/113
- IPC分类号： C12N15/113
摘要：
The present invention provides iRNA agents, e.g., double stranded iRNA agents, that target the transthyretin (TTR) gene and methods of using such iRNA agents for treating or preventing TTR-associated diseases.
公开/授权文献
信息查询
IPC分类:
